Which hedge funds own MLTX? MOONLAKE IMMUNOTHERAPEUTICS, Q2 2026 13F holders
Healthcare · Open on the interactive board
8 of the hedge funds tracked by WhaleCreep disclosed a position in MLTX (MOONLAKE IMMUNOTHERAPEUTICS) in their Q2 2026 13F filings, worth $168.1m in total. The largest holder by portfolio weight is D. E. Shaw & Co at 0.0% of its book. 3 exited: Avidity Partners, Brevan Howard Capital Management, Casdin Capital.
8tracked managers holding
0opened this quarter
3exited this quarter
Which hedge funds hold MLTX? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| D. E. Shaw & Co | Q2 2026 | 0.0% | $65.5m | 3,365,507 | 41% | added |
| Point72 Asset Management LP | Q2 2026 | 0.0% | $22.6m | 1,158,732 | -15% | reduced |
| Citadel Advisors | Q2 2026 | 0.0% | $38.4m | 1,972,893 | 49% | added |
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $12.5m | 643,268 | 132% | added |
| Holocene Advisors | Q2 2026 | 0.0% | $4.9m | 250,000 | -58% | reduced |
| Marshall Wace | Q2 2026 | 0.0% | $10.7m | 550,351 | 394% | added |
| Millennium Management | Q2 2026 | 0.0% | $12.4m | 636,187 | 10% | added |
| Tudor Investment | Q2 2026 | 0.0% | $1.1m | 58,740 | -5% | reduced |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Avidity Partners | 3.6% | $932.0k |
| Brevan Howard Capital Management | 0.1% | $605.9k |
| Casdin Capital | 23.2% | $8.4m |
How has hedge fund ownership of MLTX changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 8 | $168.1m |
| Q1 2026 | 11 | $135.0m |
| Q4 2025 | 4 | $14.0m |
| Q3 2025 | 2 | $506.6k |
| Q2 2025 | 4 | $26.8m |
| Q1 2025 | 3 | $20.2m |
| Q4 2024 | 3 | $107.1m |
| Q3 2024 | 3 | $93.2m |
| Q2 2024 | 3 | $82.7m |
| Q1 2024 | 4 | $89.5m |
| Q4 2023 | 6 | $82.8m |
| Q3 2023 | 6 | $61.1m |
| Q2 2023 | 4 | $24.4m |
| Q1 2023 | 2 | $1.1m |
| Q4 2022 | 1 | $122.0k |
| Q3 2022 | 1 | $2.6m |
Counts every tracked manager that disclosed MLTX in that quarter's filing, including managers that have since stopped filing.